05:31 PM EDT, 06/04/2024 (MT Newswires) -- Jon Faiz Kayyem, Director, on May 31, 2024, executed a purchase for 286,786 shares in Inhibrx Biosciences ( INBX ) for $4,927,580. Following the Form 4 filing with the SEC, Kayyem has control over a total of 1,092,861 shares of the company, with 1,092,861 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2007919/000200791924000006/xslF345X03/wk-form4_1717536444.xml

Price: 17.48, Change: +0.27, Percent Change: +1.57